Focus Stocks
Top Biotech Movers (IDRA, ENMD, BPAX, VVUS, SQNM)
Published on Friday, 23 December 2011 18:04 Written by Paul Oldrini
New York, December 23rd (TradersHuddle.com) - Idera Pharmaceuticals (NASDAQ:IDRA) was one of the biggest gainers, surging 13.40% to $1.10 on unusual volume of 50K shares, bouncing back from its low. Earlier this week, the stock had breached a $1 level. The stock has a 52-week range of $0.95-$3.73.
EntreMed (NASDAQ:ENMD) bounced back sharply and ended higher by 12.90% to $1.05, after slumping over 35% during the past one week. Earlier this week, the stock had made a new 52-week low of $0.90. The company has a market capitalization of $12.85 million.
BioSante Pharmaceuticals (NASDAQ:BPAX) continued to show volatile moves after recent fall, which pulled the stock to new 52-week low of $0.38 earlier this week after reporting that LibiGel (testosterone gel) unable meet the co-primary or secondary endpoints in two Phase III trials.
VIVUS (NASDAQ:VVUS) stock bounced back 5.71% to $9.17 after slumping over 17% in the previous trading session on new safety data related to its proposed diet drug Qnexa. VIVUS is a biopharmaceutical company. The Company is engaged in development and commercialization of therapeutic drugs for large underserved markets, including obesity and related morbidities, such as sleep apnea and diabetes and men's sexual health.
Sequenom (NASDAQ:SQNM) continued to edged higher and closed up 3.90% at $4.26. The stock has jumped over 14% in the past one week after falling to its 52-week low of $3.57 earlier in December. Today, more than 2.22 million shares traded hands, compared to its average volume of 2.19 million shares.
Related Articles
- Idera Pharmaceuticals Reports First Quarter 2012 Financial Results
- BioSante Pharmaceuticals Reports First Quarter Financial Results
- VIVUS Reports First Quarter 2012 Financial Results
- Idera Pharmaceuticals Announces Efficacy Data for IMO-8400 in Preclinical Models of Lupus and Psoriasis
- Biotech Takeovers: Who’s Next On The Block?
- VIVUS to Present at Three Investor Conferences in May
- Idera Pharmaceuticals Announces Top-line Results from a Phase 2 Clinical Trial of IMO-2055 in Treatment of Patients with Advanced Head and Neck Cancer
- Idera Pharmaceuticals Announces Presentation of Preclinical Data of IMO-8400 in Both Lupus and Psoriasis Models
- VIVUS Announces Date of First Quarter 2012 Financial Results and Conference Call
- VIVUS Appoints Ernest Mario, Ph.D. to the Board of Directors
Related Partner Headlines
- Slow, but Positive - TheStreet.com
- Sequenom Provides Update on Agreement With Coventry Health Care - Benzinga
- EntreMed Regains Nasdaq Compliance With Shareholders' Equity Listing Requirement - Benzinga
- Sequenom Inc. (SQNM): Today's Featured Drugs Winner - TheStreet.com
- UPDATE: Oppenheimer Raises PT of Sequenom to $10 - Benzinga
- UPDATE: Vivus Announces FDA Approval Of STENDRA Tablets For The Treatment Of Erectile Dysfunction - Benzinga
- UPDATE: Credit Suisse Assumes Outperform, Cuts PT to $34 on Vivus; Qnexa REMS - Benzinga
- Sequenom Stock Hits New 52-Week Low (SQNM) - TheStreet.com
- Return of the Dip-Buyers - TheStreet.com
- Wedbush: Sequenom Has No Room for Missteps - Benzinga
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
Three Drivers To HP's Earnings - TheStreet.com -
Market Preview: Reality Check - TheStreet.com -
The Hoopla Point of No Return - TheStreet.com -
Dell, PetSmart: After-Hours Headlines - TheStreet.com -
China's Domestic Economy in Slowdown Mode - TheStreet.com -
Ford Hails Credit Upgrade as 'Once-in-a-Lifetime Event' - TheStreet.com -
The Easy Money Has Been Made - TheStreet.com -
F5 Networks Inc. (FFIV): Today's Featured Computer Software & Services Loser - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,502.81 Trade time:4:04PM EDT Value change:▼1.67 (-0.01%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,316.63 Trade time:4:32PM EDT Value change:▲0.64 (0.05%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.08 Trade time:5:16PM EDT Value change:▼8.13 (-0.29%)In The Wires
-
Coalspur Substantially Increases Existing Vista South Coal Resources -
CORRECTING and REPLACING Rambus To Present at the Barclays Global Technology, Media and Telecommunications Conference -
Euronet Deploys the First Independent and Shared Automated Deposit Terminal Networks in Europe -
Duluth Metals Announces Normal Course Issuer Bid and Securities Repurchase Plan for its Class A Shares -
Howard Bancorp, Inc. Commences Previously Announced Rights Offering and Public Offering -
TriCo Bancshares Announces Quarterly Cash Dividend -
WestJet introduces new unaccompanied minor program -
Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting









